Evidence map›Paper›PMID 38347147›Full record

ArticleNature structural & molecular biology2024

Protein destabilization underlies pathogenic missense mutations in ARID1B.

Fanny Mermet-Meillon, Samuele Mercan, Beatrice Bauer-Probst, Cyril Allard, Melusine Bleu, Keith Calkins, Judith Knehr, Marc Altorfer, Ulrike Naumann, Kathleen Sprouffske and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cancer-associated TRF1 mutations alter PARP1 interaction dynamics: an in silico study.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Fanny Mermet-Meillon *Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland.
Samuele Mercan *Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland.
Beatrice Bauer-ProbstDisease Area Oncology, Novartis Biomedical Research, Basel, Switzerland.
Cyril AllardDisease Area Immunology, Novartis Biomedical Research, Basel, Switzerland.
Melusine BleuDisease Area Oncology, Novartis Biomedical Research, Basel, Switzerland.
Keith CalkinsDisease Area Oncology, Novartis Biomedical Research, Basel, Switzerland.
Judith KnehrDiscovery Sciences, Novartis Biomedical Research, Basel, Switzerland.
Marc AltorferDiscovery Sciences, Novartis Biomedical Research, Basel, Switzerland.ORCID http://orcid.org/0009-0004-6074-5087
Ulrike NaumannDiscovery Sciences, Novartis Biomedical Research, Basel, Switzerland.ORCID http://orcid.org/0000-0001-7783-7675
Kathleen SprouffskeDisease Area Oncology, Novartis Biomedical Research, Basel, Switzerland.ORCID http://orcid.org/0000-0001-7081-2598
Louise BarysDisease Area Oncology, Novartis Biomedical Research, Basel, Switzerland.
Fabian SesterhennDiscovery Sciences, Novartis Biomedical Research, Basel, Switzerland. fabian.sesterhenn@novartis.com.ORCID http://orcid.org/0000-0001-8331-4344
Giorgio G GalliDisease Area Oncology, Novartis Biomedical Research, Basel, Switzerland. giorgio.galli@novartis.com.ORCID http://orcid.org/0000-0002-9401-060X
Novartis (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ARID1B is a SWI/SNF subunit frequently mutated in human Coffin-Siris syndrome (CSS) and it is necessary for proliferation of ARID1A mutant cancers. While most CSS ARID1B aberrations introduce frameshifts or stop codons, the functional consequence of missense mutations found in ARID1B is unclear. We here perform saturated mutagenesis screens on ARID1B and demonstrate that protein destabilization is the main mechanism associated with pathogenic missense mutations in patients with Coffin-Siris Syndrome.

Indexed as

DNA-Binding ProteinsHand Deformities, CongenitalIntellectual DisabilityMicrognathismMutation, MissenseProtein StabilityTranscription FactorsAbnormalities, MultipleFaceHumansNeckARID1B protein, humanDNA-Binding ProteinsTranscription Factors

Identifiers

PMID38347147
PMCPMC11257965
OpenAlexW4391747044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.